WebNews

Please enter a web search for web results.

NewsWeb

markets. businessinsider. com
markets. businessinsider. com > news > stocks > live-oak-bank-grant-supports-lower-cape-fear-lifecare-hospice-nurses-addresses-growing-care-shortage-in-north-carolina-1035980155

Live Oak Bank Grant Supports Lower Cape Fear Life Care Hospice Nurses, Addresses Growing Care Shortage in North Carolina

2+ week, 3+ day ago  (302+ words) WILMINGTON, N. C. , March 31, 2026 (GLOBE NEWSWIRE) -- Live Oak Bank is highlighting the impact of a $300, 000 grant to the Lower Cape Fear Life Care Scholars program. Life Care Scholars is designed to recruit, train, and retain registered nurses in hospice and palliative care,…...

markets. businessinsider. com
markets. businessinsider. com > news > stocks > boundless-bio-presents-preclinical-breast-cancer-data-from-its-oral-kinesin-degrader-program-at-2026-aacr-annual-meeting-1036034698

Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting

20+ hour, 42+ min ago  (500+ words) Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ec DNA) biology to deliver transformative therapies to patients with previously intractable oncogene. .. Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual…...

markets. businessinsider. com
markets. businessinsider. com > news > stocks > beond-establishes-u-s-headquarters-in-austin-as-texas-leads-the-nation-into-a-new-era-of-brain-health-1036033999

Beond Establishes U. S. Headquarters in Austin as Texas Leads the Nation Into a New Era of Brain Health

1+ day, 37+ min ago  (968+ words) Texas is rewriting the future of mental health. With a $100 million commitment to ibogaine research, a growing coalition of clinicians, policymakers, and researchers, and a culture built on tackling. .. Beond Establishes U. S. Headquarters in Austin as Texas Leads the Nation Into…...

markets. businessinsider. com
markets. businessinsider. com > news > stocks > kadima-wealth-publishes-retirement-planning-advice-for-well-off-individuals-approaching-retirement-age-1036030095

Kadima Wealth Publishes Retirement Planning Advice for Well-off Individuals Approaching Retirement Age

2+ day, 1+ hour ago  (472+ words) By Elias Friedman, Founder & Wealth Advisor at Kadima Wealth, three retirement planning concerns are addressed that could impact taxes, income, and asset protection for clients. United States, April 16, 2026 -- The new guidelines on retirement planning have been launched by Kadima Wealth,…...

markets. businessinsider. com
markets. businessinsider. com > news > stocks > ose-immunotherapeutics-to-present-a-novel-first-in-class-fpr2-agonist-monoclonal-antibody-in-the-resolution-of-chronic-inflammation-at-the-aai-2026-meeting-1036023346

OSE Immunotherapeutics to Present a Novel, First-in-Class, FPR2 Agonist Monoclonal Antibody in the Resolution of Chronic Inflammation at the AAI 2026 Meeting

3+ day, 12+ hour ago  (177+ words) OSE Immunotherapeutics to Present a Novel, First-in-Class, FPR2 Agonist Monoclonal Antibody in the Resolution of Chronic Inflammation at the AAI 2026 Meeting Aurore Morello, Ph D, Chief Scientific Officer of OSE Immunotherapeutics, will unveil for the first time a novel, first'in'class therapeutic…...

markets. businessinsider. com
markets. businessinsider. com > news > stocks > picard-medical-syncardia-highlights-total-artificial-heart-bridge-to-transplant-case-at-texas-children-s-hospital-1036024505

Picard Medical / Syn Cardia Highlights Total Artificial Heart Bridge to Transplant Case at Texas Children's Hospital

2+ day, 16+ hour ago  (735+ words) Picard Medical, Inc. (NYSE American: PMI) (Picard Medical" or the Company"), parent company of Syn Cardia Systems, LLC, maker of the world's first total artificial heart approved by both the U. S. FDA. .. Picard Medical / Syn Cardia Highlights Total Artificial Heart Bridge…...

markets. businessinsider. com
markets. businessinsider. com > news > stocks > cardiff-oncology-presents-preclinical-data-on-its-plk1-inhibitor-onvansertib-in-combination-with-a-her2-targeted-adc-at-the-2026-aacr-annual-meeting-1036034575

Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting

8+ hour, 49+ min ago  (296+ words) Following the presentation on April 19, 2026 from 2: 005: 00 PM PT, the poster titled "PLK1 inhibitor onvansertib potentiates the antitumor efficacy of trastuzumab deruxtecan (T-DXd) and reverses its. .. Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at…...

markets. businessinsider. com
markets. businessinsider. com > news > stocks > myriad-genetics-to-deliver-six-abstracts-including-two-podiums-at-aacr-2026-1036029182

Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026

1+ day, 15+ hour ago  (411+ words) SALT LAKE CITY, April 16, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced that it will share six abstracts, including two podium presentations, at the American Association for Cancer Research (AACR) Annual…...

markets. businessinsider. com
markets. businessinsider. com > news > stocks > oric-pharmaceuticals-presents-preclinical-data-to-support-the-potential-of-rinzimetostat-across-prostate-cancer-and-in-emerging-resistance-settings-at-the-2026-american-association-for-cancer-1036034581

ORIC" Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer. ..

21+ hour, 26+ min ago  (359+ words) ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the presentation of. .. SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 17, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC),…...

markets. businessinsider. com
markets. businessinsider. com > news > stocks > verisk-analytics-inc-prices-offering-of-senior-notes-1035857679

Verisk Analytics, Inc. Prices Offering of Senior Notes

1+ mon, 3+ week ago  (696+ words) JERSEY CITY, N. J. , Feb. 23, 2026 (GLOBE NEWSWIRE) -- Verisk Analytics, Inc. (Nasdaq: VRSK) (Verisk" or the Company"), a leading strategic data analytics and technology partner to the global. .. Verisk Analytics, Inc. Prices Offering of Senior Notes JERSEY CITY, N. J. , Feb. 23, 2026 (GLOBE NEWSWIRE) -- Verisk Analytics,…...